Over 100 people under investigation for vape offences, say MOH and HSA
Source: Straits Times
Article Date: 15 Aug 2025
Author: Nadine Chua
More than 100 people are under investigation for offences involving vapes, said the Ministry of Health (MOH) and the Health Sciences Authority (HSA) on Aug 14.
More than 100 people are under investigation for offences involving vapes, said the Ministry of Health (MOH) and the Health Sciences Authority (HSA) on Aug 14.
In a joint statement, MOH and HSA said 18 individuals are facing charges in court for offences under the Tobacco (Control of Advertisements and Sale) Act involving the sale, advertising or import of e-vaporisers.
As at Aug 14, five people have been charged over the sale or importation of etomidate-laced e-vaporisers. HSA is also investigating about 65 cases involving the possession, sale or importation of etomidate-laced e-vaporisers.
Another 100 are under investigation for offences involving non-etomidate e-vaporisers under the Tobacco (Control of Advertisements and Sale) Act, said the authorities.
They said: 'MOH and HSA have been intensifying enforcement actions against etomidate-laced e-vaporiser offences in Singapore.'
Under the Poisons Act, those convicted of possessing, importing or selling pods containing etomidate can be jailed for up to two years and/or fined up to $10,000.
MOH and HSA said etomidate will soon be classified as a Class C controlled drug under the Misuse of Drugs Act.
Offenders caught using etomidate-laced e-vaporisers will be subject to mandatory supervision and rehabilitation. Repeat offenders are liable to be prosecuted and subject to jail for at least a year.
More severe penalties apply to those selling, distributing or importing these devices, including imprisonment of up to 20 years and caning.
'Users of e-vaporisers, particularly those consuming etomidate, are strongly urged to cease consumption immediately,' said MOH and HSA.
The increase in enforcement numbers comes after The Straits Times launched its anti-vaping campaign called Vaping: The Invisible Crisis on July 13.
Etomidate is meant for use only during medical procedures. When vaped, etomidate enters the lungs directly, potentially triggering spasms, breathing difficulties, seizures and even psychosis.
If etomidate is listed as a Class C drug, abusers can be subjected to supervision and mandatory participation in a rehabilitation programme or committed to drug rehabilitation centres, similar to what drug abusers undergo.
Under current laws, possessing, using or buying vapes carries a maximum fine of $2,000.
Those found in possession of or using pods containing etomidate can be jailed for up to two years and fined up to $10,000.
The measures listed in the MOH-HSA joint statement are among the latest the authorities have taken to tackle the vape scourge in Singapore.
On Aug 13, HSA said it was working with Hong Kong's Department of Health (DOH) to tackle vaping by exchanging information and expertise with each other. HSA signed a memorandum of understanding with the DOH for cooperation in healthcare regulatory matters involving health products.
Also on Aug 13, ST reported HSA had recently advertised job openings for investigators specifically to crack down on Kpods. As at Aug 14, more than 500 people have applied for the job.
The public can report vaping offences to the Tobacco Regulation Branch on 6684-2036 or 6684-2037 from 9am to 9pm daily, or online at www.go.gov.sg/reportvape
Those who need help to quit vaping can join the Health Promotion Board's I Quit programme by calling the QuitLine on 1800-438-2000.
The authorities have said those who voluntarily seek support to quit vaping will not face any penalties for doing so.
Source: The Straits Times © SPH Media Limited. Permission required for reproduction.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
6 hours ago
- Straits Times
More support for special needs patients as Singapore recognises special care dentistry
Sign up now: Get ST's newsletters delivered to your inbox Cerebral palsy patient Hillary Chua with her mother, Ms Cindy Wong, and Dr Tay Chong Meng, division head of advanced general dental practice at the National University Centre for Oral Health Singapore. SINGAPORE – Born with quadriplegic cerebral palsy, 22-year-old Hillary Chua uses a wheelchair and cannot perform daily functions independently. Her 57-year-old mother, Ms Cindy Wong, has been taking care of her full-time, including diligently cleaning her teeth. Finding a dentist who is trained to treat special needs patients was challenging. Then, during the Covid-19 pandemic, Ms Wong stopped dentist visits altogether because of restrictions. In 2024, she noticed a bad odour from her daughter's mouth. They were referred to the National University Centre for Oral Health Singapore (Nucohs), where Ms Chua was treated by Dr Tay Chong Meng, division head of advanced general dental practice. Dr Tay and his team carefully assessed her needs, as well as the unique challenges posed by her condition, and put together a tailored treatment plan prioritising her safety and comfort. They worked with her mother in providing head support for Ms Chua – who occasionally has sudden head movements due to her lack of muscle control – and trying out various positions to reach her inner teeth, which is challenging as she has difficulty opening her mouth. Dr Tay is among Singapore's growing cohort of special care dentists, an area of specialisation that was officially recognised in July. The Ministry of Health (MOH) announced that the Dental Specialists Accreditation Board (DSAB) will recognise special care dentistry as the eighth dental speciality, joining others such as oral and maxillofacial surgery, orthodontics and paediatric dentistry. 'The new dental speciality addresses the growing need for specialised dental care, particularly in the light of Singapore's ageing population,' MOH had said. Specialists in the field look after the oral healthcare of adults with complex needs, such as those with physical, developmental or cognitive conditions that prevent them from receiving routine dental care. The ministry noted that difficulties in getting appropriate dental care could mean that such individuals face an increased risk of oral diseases, such as dental caries or tooth decay and periodontal disease. This, in turn, could significantly impact their oral function, general health and quality of life, it said. 'The recognition of special care dentistry as a dental speciality will support professional development and encourage more dental practitioners to pursue advanced training in this field,' it added. The DSAB will establish professional standards, as well as enhance training competencies, to ensure dental specialists meet quality care standards. Special care dentistry is also recognised as a speciality in several other countries, such as Australia, Malaysia and Britain. While this field does not have a set of specialised procedures, its practitioners have a better understanding of the relationship between patients' medical condition and their oral health, and are trained in behavioural management. For example, patients with conditions such as autism spectrum disorder or Down syndrome may face anxiety when undergoing dental procedures. 'Careful use of suction, with a lot of reassurance and distraction, will help reduce the anxiety triggered by involuntary salivary flow whenever the mouth is stretched for dental assessment and treatment,' Dr Tay said. Both Nucohs and NDCS have special equipment for those with special needs, such as a wheelchair-tilter, which allows patients with mobility issues to remain in their wheelchairs during treatment. Noting that people with special needs and their caregivers may face difficulty in finding dental practitioners confident in managing challenging cases, Dr Tay said the recognition of the field as a speciality raises awareness that additional help is available for such patients. 'This recognition is also an acknowledgement of the work and efforts by our colleagues to manage the oral health challenges of people with special needs,' he said. Dr Yang Jingrong, who heads the Geriatric and Special Care Dentistry Clinic at the National Dental Centre Singapore (NDCS), said the recognition validates the 'unique skill set and expertise required in treating patients with special needs'. 'This leads to an improved professional identity and better defined scope of practice,' she added. Dr Tay told The Straits Times that visits by special needs patients to Nucohs have been increasing, from about 1,200 in 2022 to about 1,500 in 2023. This could be due to a number of reasons, he said, including greater awareness of the importance of oral health and the extension of government subsidies for special needs outpatients at Nucohs. Dr Tay noted that carrying out simple procedures takes only slightly longer for patients with special needs in most cases. However, there are cases who need a 'significantly longer' time, even taking several visits, depending on the individual. One example is a patient with dental tartar that is significantly bulky or under the gums. 'Then we might need a few visits to build their confidence with under-the gums-scaling,' Dr Tay said, referring to a procedure to remove plaque and tartar build-up below the gum line. He added that the dental team works with caregivers to help introduce patients to a 'realistic and sustainable oral care regime' at home, such as the use of a water pick for those uncomfortable with flossing. Patients can also benefit from targeted dental products that further protect their oral health. 'Improved access to certain therapeutic products, such as high-strength fluoride toothpaste, can allow the caries, or tooth decay, risk to be controlled more appropriately, enhancing the preventive benefits of these products to persons with special healthcare needs,' said Dr Yang. 'Additionally, there can be more education as a whole for caregivers on how to perform oral care for patients with special care needs, as well as modifications to be aware of, such as for persons with swallowing difficulties or with cognitive impairment.' For Ms Wong, the special care services at Nucohs are a major reason why she is willing to take her daughter all the way to the centre in Kent Ridge from their home in Punggol. Aware that her daughter had developed a phobia of doctors after previously undergoing surgery, Dr Tay put her at ease by referring to himself as 'uncle' and being friendly towards her. 'It was the first time I met a doctor who called himself uncle,' said Ms Wong.
Singapore Law Watch
13 hours ago
- Singapore Law Watch
Over 100 people under investigation for vape offences, say MOH and HSA
Over 100 people under investigation for vape offences, say MOH and HSA Source: Straits Times Article Date: 15 Aug 2025 Author: Nadine Chua More than 100 people are under investigation for offences involving vapes, said the Ministry of Health (MOH) and the Health Sciences Authority (HSA) on Aug 14. More than 100 people are under investigation for offences involving vapes, said the Ministry of Health (MOH) and the Health Sciences Authority (HSA) on Aug 14. In a joint statement, MOH and HSA said 18 individuals are facing charges in court for offences under the Tobacco (Control of Advertisements and Sale) Act involving the sale, advertising or import of e-vaporisers. As at Aug 14, five people have been charged over the sale or importation of etomidate-laced e-vaporisers. HSA is also investigating about 65 cases involving the possession, sale or importation of etomidate-laced e-vaporisers. Another 100 are under investigation for offences involving non-etomidate e-vaporisers under the Tobacco (Control of Advertisements and Sale) Act, said the authorities. They said: 'MOH and HSA have been intensifying enforcement actions against etomidate-laced e-vaporiser offences in Singapore.' Under the Poisons Act, those convicted of possessing, importing or selling pods containing etomidate can be jailed for up to two years and/or fined up to $10,000. MOH and HSA said etomidate will soon be classified as a Class C controlled drug under the Misuse of Drugs Act. Offenders caught using etomidate-laced e-vaporisers will be subject to mandatory supervision and rehabilitation. Repeat offenders are liable to be prosecuted and subject to jail for at least a year. More severe penalties apply to those selling, distributing or importing these devices, including imprisonment of up to 20 years and caning. 'Users of e-vaporisers, particularly those consuming etomidate, are strongly urged to cease consumption immediately,' said MOH and HSA. The increase in enforcement numbers comes after The Straits Times launched its anti-vaping campaign called Vaping: The Invisible Crisis on July 13. Etomidate is meant for use only during medical procedures. When vaped, etomidate enters the lungs directly, potentially triggering spasms, breathing difficulties, seizures and even psychosis. If etomidate is listed as a Class C drug, abusers can be subjected to supervision and mandatory participation in a rehabilitation programme or committed to drug rehabilitation centres, similar to what drug abusers undergo. Under current laws, possessing, using or buying vapes carries a maximum fine of $2,000. Those found in possession of or using pods containing etomidate can be jailed for up to two years and fined up to $10,000. The measures listed in the MOH-HSA joint statement are among the latest the authorities have taken to tackle the vape scourge in Singapore. On Aug 13, HSA said it was working with Hong Kong's Department of Health (DOH) to tackle vaping by exchanging information and expertise with each other. HSA signed a memorandum of understanding with the DOH for cooperation in healthcare regulatory matters involving health products. Also on Aug 13, ST reported HSA had recently advertised job openings for investigators specifically to crack down on Kpods. As at Aug 14, more than 500 people have applied for the job. The public can report vaping offences to the Tobacco Regulation Branch on 6684-2036 or 6684-2037 from 9am to 9pm daily, or online at Those who need help to quit vaping can join the Health Promotion Board's I Quit programme by calling the QuitLine on 1800-438-2000. The authorities have said those who voluntarily seek support to quit vaping will not face any penalties for doing so. Source: The Straits Times © SPH Media Limited. Permission required for reproduction. Print
CNA
14 hours ago
- CNA
Cordlife sets aside S$500,000 for enhanced compensation package to affected customers
SINGAPORE: Cordlife has set aside S$500,000 (US$389,500) for an enhanced compensation package for affected customers following its mishandling of cord blood units. In a regulatory filing on its financial results for the first half of 2025, the private cord blood bank said late on Thursday (Aug 14) that the compensation package formed part of several one-off costs recorded for the first six months of the year. Cordlife added that it had also incurred S$200,000 in costs related to the testing of more than 200 samples of cord blood units (CBU) from five storage tanks deemed by the Ministry of Health (MOH) to be at "low risk" of being adversely affected. The company agreed to the testing in April 2024, which it said would take approximately a year to complete, before reviewing the results with MOH experts. In an update on Thursday, Cordlife said the "comprehensive and independent" review is expected to be completed in or around the later part of 2025. As part of the enhanced package, announced on Jul 10, affected customers will have their existing cord blood storage period extended - at no additional cost - until their child turns 26. The package was announced after Cordlife held a series of online and in-person townhalls in late June to engage with affected customers. It has since expanded the warranty clause to cover more situations. If the stored cord blood unit is needed by the donor or a biological sibling (and it is a suitable match) but cannot be used for an approved stem cell transplant because it does not meet the required quality standards - and if the company also cannot find a suitable replacement cord blood unit - it will pay the affected customer S$50,000. In June, Cordlife said in a regulatory filing that around 56 per cent of affected Cordlife customers had accepted refund offers made by the company. The offers comprised a refund of the annual fees paid by affected clients from the onset of the "temperature excursion". Its mishandling of cord blood units was first made public on Nov 30, 2023, when MOH revealed that investigations were ongoing. Seven tanks storing cord blood units were exposed to temperatures above acceptable limits. About 2,200 cord blood units were found damaged in one of the tanks, affecting at least 2,150 clients. In April last year, it was announced that another 5,300 cord blood units in a second tank and dry shipper were deemed "non-viable". LETTERS OF DEMAND Some affected customers have decided to take legal action against the company. In a separate bourse update on the matter on Thursday, Cordlife said it had received on Jul 31 a letter of demand from a law firm acting for a group of affected clients. This group is claiming damages for breach of contract and negligence. The company added that total customer claims amount to about S$8.7 million, representing less than 10 per cent of its net asset value as of Jun 30. Cordlife previously said it had received on Mar 28 two letters of demand from lawyers acting for two groups of affected clients. One of the groups is claiming damages for breach of contract and negligence, while the other group is requesting compensation for costs, among other warranties and undertakings from Cordlife. The company received its first letter of demand in May last year, while two other announcements were made on Aug 15, 2024 and Mar 1 on the same matter. ACCREDITATION, IMPROVED FINANCIALS Cordlife also said on Thursday it is working closely with the Association for the Advancement of Blood & Biotherapies (AABB) and the Foundation for the Accreditation of Cellular Therapy (FACT) to restore its accreditations for its Singapore operations. In December 2023, it lost its cellular therapy accreditation with FACT. The suspension will last indefinitely, "at a minimum until FACT's investigations are completed and issues are resolved", Cordlife then said. AABB followed suit in August last year, with the international blood bank body withdrawing Cordlife's accreditation for the collection, processing, storage and distribution of cord blood. On its financial results for the first half of this year, the company reported revenue of S$19.4 million - more than double the S$9.2 million it earned in the same period last year. Cordlife mainly attributed the increase in revenue to the full resumption of Singapore operations in January, after being suspended for almost nine months. The company's gross profit also rose to S$10.9 million in the first half of 2025, up from S$1.4 million in the corresponding period a year ago. Cordlife said it remains "cautiously optimistic" that financial performance will improve, driven by the resumption of Singapore operations, ongoing efforts at actively addressing outstanding issues and the "long-term growth potential" of the cord blood banking industry. Said Cordlife group CEO and executive director Chen Xiaoling: 'We continue to see new business opportunities, and have been investing in our sales and marketing efforts to restore customer confidence and grow our sales pipeline back to pre-incident levels.
